These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1680550

  • 1. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH, Licht T, Merlino GT, Gottesman MM, Pastan I.
    Cancer Res; 1991 Oct 01; 51(19):5417-24. PubMed ID: 1680550
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
    Mickisch GH, Pai LH, Gottesman MM, Pastan I.
    Cancer Res; 1992 Aug 15; 52(16):4427-32. PubMed ID: 1353705
    [Abstract] [Full Text] [Related]

  • 3. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.
    Mickisch GH, Merlino GT, Galski H, Gottesman MM, Pastan I.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):547-51. PubMed ID: 1671173
    [Abstract] [Full Text] [Related]

  • 4. Multidrug resistant transgenic mice as a novel pharmacologic tool.
    Mickisch GH, Pastan I, Gottesman MM.
    Bioessays; 1991 Aug 15; 13(8):381-7. PubMed ID: 1683231
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM.
    Cancer Res; 1995 Mar 01; 55(5):1086-91. PubMed ID: 7866993
    [Abstract] [Full Text] [Related]

  • 6. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
    Hanania EG, Deisseroth AB.
    Clin Cancer Res; 1997 Feb 01; 3(2):281-6. PubMed ID: 9815684
    [Abstract] [Full Text] [Related]

  • 8. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
    Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC.
    Mol Pharmacol; 1991 Oct 01; 40(4):490-4. PubMed ID: 1681415
    [Abstract] [Full Text] [Related]

  • 9. Molecular targets in oncology: implications of the multidrug resistance gene.
    Lum BL, Gosland MP, Kaubisch S, Sikic BI.
    Pharmacotherapy; 1993 Oct 01; 13(2):88-109. PubMed ID: 8097038
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma.
    Wang Y, Jin XQ, Wang S, Wang Q, Luo Q, Luo XJ.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):545-51. PubMed ID: 17085340
    [Abstract] [Full Text] [Related]

  • 11. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
    Mickisch GH, Merlino GT, Aiken PM, Gottesman MM, Pastan I.
    J Urol; 1991 Aug 01; 146(2):447-53. PubMed ID: 1677434
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.
    Cancer Chemother Pharmacol; 2005 Aug 01; 56(2):173-81. PubMed ID: 15824923
    [Abstract] [Full Text] [Related]

  • 13. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T.
    J Gene Med; 2003 May 01; 5(5):366-76. PubMed ID: 12731085
    [Abstract] [Full Text] [Related]

  • 14. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 15. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I.
    Cancer Res; 1986 Nov 01; 46(11):5941-6. PubMed ID: 3756931
    [Abstract] [Full Text] [Related]

  • 16. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT, Odeleye A, Huizenga E, Dalton WS, Weinstein RS, Grogan TM.
    Clin Cancer Res; 1995 Dec 01; 1(12):1563-70. PubMed ID: 9815957
    [Abstract] [Full Text] [Related]

  • 17. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 01; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 18. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
    Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T.
    Clin Cancer Res; 1997 Jun 01; 3(6):947-54. PubMed ID: 9815770
    [Abstract] [Full Text] [Related]

  • 19. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A, Seth K, Kalra N, Shukla Y.
    Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829
    [Abstract] [Full Text] [Related]

  • 20. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJ, Borst P.
    Cancer Res; 1990 Mar 15; 50(6):1779-85. PubMed ID: 1968359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.